Enhancement by bufalin of retinoic acid-induced differentiation of acute promyelocytic leukemia cells in primary culture

Leukemia Research

Volumn 22, Issue 7, 1998, Pages 589-595

  Yamada, Kazunari ^a   Hino, Ken Ichiro ^a   Tomoyasu, Shigeru ^a   Honma, Yoshio ^b   Tsuruoka, Nobuyoshi ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAITAMA CANCER CENTER   (Japan)

Author keywords

Acute promyelocytic leukemia; Bufalin; Differentiation; Primary culture; Retinoic acid

Indexed keywords

BUFALIN; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BUFANOLIDES; CARDIOTONIC AGENTS; CELL DIFFERENTIATION; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FEMALE; HUMANS; LEUKEMIA, MYELOID; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0031817675     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(98)00044-7     Document Type: Article

References (16)

1. Hozumi M. Fundamentals of chemotherapy of myeloid leukemia by induction of leukemia cell differentiation. Adv Cancer Res. 38:1983;121.
2. Koeffler H.P. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood. 62:1983;709.
3. Bloch A. Induced cell differentiation in cancer therapy. Cancer Treat Rep. 68:1984;199.
4. Chen K.K., Korarikova A. Pharmacology and toxicology of toad venom. J Pharm Sci. 56:1967;1535.
5. Zhang L., Nakaya K., Yoshida T., Kuroiwa Y. Bufalin as a potent inducer of differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun. 178:1991;686.
6. Zhang L., Nakaya K., Yoshida T., Kuroiwa Y. Induction of bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers. Cancer Res. 52:1992;4634.
7. Honma Y., Fujita Y., Kasukabe T., Hozumi M., Sampi K., Sakurai M., Tsushima S., Nomura H. Induction of differentiation of human acute non-lymphocytic leukemia cells in primary culture by inducers of differentiation of human myeloid leukemia cell line HL60. Eur J Cancer Clin Oncol. 19:1983;251.
8. Komatsu M., Okano T. Separation of bufo-steroids by eluting dry column chromatography on silica gel. Yakagaku Zasshi. 87:1967;712.
9. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., Sultan C. Proposals for the classification of the acute leukaemias. Br J Haematol. 33:1976;451.
10. Lanotte M., Martin-Thouvenin V., Najman S., Balerini P., Valensi F., Berger R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood. 77:1991;1080.
11. Sakashita A., Nakamaki T., Tsuruoka N., Honma Y., Hozumi M. Granulocyte colony-stimulating factor, not granulocytemacrophage colony-stimulating factor, cooperates with retinoic acid on the induction of functional N-formyl-methyonyl-phenylalanine receptors in HL-60 cells. Leukemia. 5:1991;26.
12. Kanatani Y., Kasukabe T., Okabe-Kado J., Hayashi S., YamamotoYamaguchi Y., Motoyoshi K., Nagata N., Honma Y. Transforming growth factor β and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells. Cell Growth Differ. 7:1996;187.
13. Kamm J.J. Toxicology, carcinogenicity, and teratogenicity of some orally administered retinoids. J Am Acad Dermatol. 6:1982;652.
14. Lowe N.J., David M. New retinoids for dermatologic diseases. Uses and toxicity. Dermatol Clin. 6:1988;539.
15. Mundi J.R.F., Frankel S.R., Huselton C., DeGrazia F., Garland W.A., Young C.W., Warrell R.P. Jr. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res. 52:1992;2138.
16. Comic M., Delva L., Guidez F., Balitrand N., Degos L., Chomienne C. Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients. Cancer Res. 52:1992;3329.